High-risk prostate cancer: From definition to contemporary management Review uri icon

Overview

MeSH Major

  • Androgen Antagonists
  • Antineoplastic Agents, Hormonal
  • Prostatectomy
  • Prostatic Neoplasms

abstract

  • A significant minority of patients continue to present with high-risk PCa, which remains lethal in some cases. Outcomes following treatment of men with high-risk tumors have not substantially improved over time. However, not all high-risk patients are at the same risk of PCa progression and death. At present, a multimodal approach seems the best way to achieve acceptable outcomes for high-risk PCa patients.

publication date

  • June 2012

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2012.02.031

PubMed ID

  • 22386839

Additional Document Info

start page

  • 1096

end page

  • 106

volume

  • 61

number

  • 6